WILLIAM J FEBBO
CIK 1413987 · CEO · last filed 2026-04-16
WILLIAM J FEBBO is a CEO who has filed 66 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for MYO, was dated Apr 16, 2026. Across all open-market trades the lifetime net is −$11.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.74M
7
66
-$11.49M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MYO | Director | 45,000 | $1.15 | $51.7K | $0 | 1 | 2026-04-16 |
| OPRX | CEO | 600,852 | $5.23 | $3.14M | -$11.56M | 32 | 2025-02-20 |
| Augmedix, Inc. (AUGX) Delisted | Director | 162,583 | $2.35 | $382.1K | $59.7K | 6 | 2024-07-15 |
| MODD | Director | 91,605 | $4.77 | $437.0K | $0 | 8 | 2023-07-05 |
| LFMDP | Director | 450,000 | $23.36 | $10.51M | $0 | 1 | 2023-06-22 |
| Merriman Holdings, Inc (MERR) Delisted | Director | — | — | — | $0 | 1 | 2008-05-06 |
| MEM | Director | 259,271 | $44.74 | $11.60M | $15.0K | 1 | 2007-11-26 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-16 | MYO | Grant (A) | +45,000 | $0 | EDGAR |
| 2025-02-20 | OPRX | Tax (F) | −401 | -$2.7K | EDGAR |
| 2024-12-16 | OPRX | Buy (P) | +20,000 | $100.2K | EDGAR |
| 2024-10-04 | — | Disp (D) | −162,583 | -$382.1K | |
| 2024-07-15 | Augmedix, Inc. (AUGX) Delisted | Exer (M) | +21,598 | $0 | EDGAR |
| 2024-06-12 | OPRX | Mixed | +28,113 | -$7.3K | EDGAR |
| 2024-04-24 | OPRX | Grant (A) | +15,000 | $0 | EDGAR |
| 2024-04-17 | OPRX | Grant (A) | +60,000 | $0 | EDGAR |
| 2024-01-18 | OPRX | Mixed | +6,744 | -$38.2K | EDGAR |
| 2023-07-17 | Augmedix, Inc. (AUGX) Delisted | Grant (A) | — | $0 | EDGAR |